Development of resistance to Mycobacterium tuberculosis is manageable in hidradenitis suppurativa. Response to 'Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?'.

Br J Dermatol

Department of Dermatology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, U.S.A.

Published: January 2018

Download full-text PDF	Source
http://dx.doi.org/10.1111/bjd.16013	DOI Listing

Publication Analysis

hidradenitis suppurativa

development resistance

resistance mycobacterium

mycobacterium tuberculosis

tuberculosis manageable

manageable hidradenitis

suppurativa response

response 'treatment

'treatment hidradenitis

suppurativa rifampicin

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!